JosephSouferMD

Endocrinology • Waterbury, CT

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Soufer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Soufer's full profile

Already have an account?

Office
500 Chase Pkwy
3rd Fl
Waterbury, CT 06708
Phone+1 203-574-2930

Fax+1 203-574-2933
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1982
Yale-New Haven Medical CenterResidency, Internal Medicine, 1977 - 1980
Universite Libre de Bruxelles Faculty of MedicineClass of 1977

Certifications & Licensure

CT State Medical License 1979 - 2025
NY State Medical License 1980 - 2024
American Board of Internal Medicine Internal Medicine

Clinical Trials

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Start of enrollment: 2010 Mar 01
Completed
Phase 3
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee Start of enrollment: 2014 Jun 01
Unknown status
Not Applicable
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Completed
Phase 2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Completed
Phase 2
Join now to see all

Press Mentions

Tamer Ghaly, MD, a Pain Management Specialist with Valley Orthopedic SpecialistsJuly 2nd, 2021